Updated OMIC consents for ROP and Retina

April 7, 2022

Dear OMIC Insureds:

With over 100 consent forms available on the OMIC website, we are pleased to announce two UPDATED ROP consent forms and a NEW retina consent form:

· ROP laser surgery

· ROP injection to treat

· Retina: Vabysmo

COMING SOON: an update to the ROP Safety Net based on the International Classification of Retinopathy of Prematurity, Third Edition (ICROP3).

If you have questions, contact us for confidential risk management advice at riskmanagement@omic.com. Or call us at 1-800-562-6642, enter 4 for Risk Management.

Sincerely,
Michelle Pineda, MBA, OMIC Risk Manager

CONFIDENTIALITY NOTICE: This correspondence is intended only for the person or entity to which it is addressed and may contain information that is privileged, confidential or otherwise protected from disclosure. Dissemination, distribution or copying of this e-mail or the information herein by anyone other than the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, is prohibited. If you have received this e-mail in error, please call me and destroy the original message and all copies.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.

Risk Management

Updated OMIC consents for ROP and Retina